CD86 and chronic kidney disease: To validate the network pharmacology results, we looked further into macrophage immunophenotype expression and found that CKD rats had higher levels of CD68, CD86, and CD206, while the JPYS formula may have caused downregulation of macrophage surface marker expression in CKD.